Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
51 studies found for:    "myasthenia gravis"
Show Display Options
Rank Status Study
21 Completed A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: Tacrolimus capsule;   Drug: Placebo
22 Recruiting Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: IGIV-C;   Drug: Placebo
23 Completed Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: eculizumab;   Drug: Placebo
24 Completed Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Condition: Refractory Generalized Myasthenia Gravis
Interventions: Biological: Eculizumab;   Drug: Placebo
25 Completed A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
Condition: Myasthenia Gravis Generalised
Interventions: Drug: mycophenolate mofetil [CellCept];   Drug: Placebo
26 Recruiting A Study Evaluating the Safety and Efficacy of Rituximab in Patients With Myasthenia Gravis
Condition: Generalized Myasthenia Gravis
Interventions: Drug: Rituximab;   Drug: Sodium Chloride solution
27 Active, not recruiting ECU-MG-302: An Extension Trial of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis
Condition: Refractory Generalized Myasthenia Gravis
Intervention: Biological: Eculizumab
28 Unknown  The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
Condition: Myasthenia Gravis
Interventions: Drug: Azathioprine;   Drug: Leflunomide
29 Recruiting A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis
Condition: Myasthenia Gravis, Generalized
Interventions: Drug: IGIV-C;   Drug: Placebo
30 Not yet recruiting A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
Condition: Myasthenia Gravis
Interventions: Biological: ARGX-113;   Drug: Placebo
31 Completed A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Condition: Myasthenia Gravis, Generalized
Interventions: Drug: mycophenolate mofetil (CellCept);   Drug: placebo
32 Terminated Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: immune globulin
33 Completed Therapeutic Plasma Exchange in MG
Condition: Myasthenia Gravis
Interventions: Other: Skin biopsy;   Other: Single Fiber Electromyography
34 Recruiting A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)
Condition: Myasthenia Gravis
Intervention: Drug: Human normal immunoglobulin G (IgG)
35 Completed Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
Conditions: Myositis;   Myasthenia Gravis
Intervention: Drug: Rituximab
36 Completed Translation, Cross-cultural Adaptation and Validation of the MGQOL-15-F
Condition: Myasthenia Gravis
Intervention:
37 Completed An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
Condition: Myasthenia Gravis
Intervention: Drug: tacrolimus
38 Active, not recruiting The Role of the Thymus in Myasthenia Gravis
Conditions: Myasthenia Gravis;   Thymoma
Intervention:
39 Terminated
Has Results
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Condition: Ocular Myasthenia Gravis
Interventions: Drug: Prednisone;   Drug: Placebo
40 Completed Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis
Condition: Myasthenia Gravid
Interventions: Biological: IVIG;   Procedure: PLEX

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-51) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.